Open Access
| Issue |
Med Sci (Paris)
Volume 41, Number 1, Janvier 2025
|
|
|---|---|---|
| Page(s) | 12 - 15 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2024186 | |
| Published online | 31 January 2025 | |
- Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010 ; 11 : 113–27. [CrossRef] [PubMed] [Google Scholar]
- Jørgensen R, Merrill AR, Yates SP, et al. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Nature 2005 ; 436 : 979–84. [CrossRef] [PubMed] [Google Scholar]
- Liu S, Milne GT, Kuremsky JG, et al. Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2. Mol Cell Biol 2004 ; 24 : 9487–97. [CrossRef] [PubMed] [Google Scholar]
- Holmes RK. Biology and molecular epidemiology of diphtheria toxin and the tox gene. J Infect Dis 2000 ; 181 : S156–67. [CrossRef] [PubMed] [Google Scholar]
- Jørgensen R, Purdy AE, Fieldhouse RJ, et al. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J Biol Chem 2008 ; 283 : 10671–8. [CrossRef] [PubMed] [Google Scholar]
- Vind AC, Snieckute G, Blasius M, et al. ZAKα recognizes stalled ribosomes through partially redundant sensor domains. Mol Cell 2020 ; 78 : 700–13. [CrossRef] [PubMed] [Google Scholar]
- Robinson KS, Toh GA, Rozario P, et al. ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome. Science 2022 ; 377 : 328–35. [CrossRef] [PubMed] [Google Scholar]
- Bauernfried S, Hornung V. Human NLRP1: From the shadows to center stage. J Exp Med 2021 ; 219 : e20211405. [Google Scholar]
- Pinilla M, Mazars R, Vergé R, et al. EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption. J Exp Med 2023 ; 220 : e20230104. [CrossRef] [PubMed] [Google Scholar]
- Urreizti R, Mayer K, Evrony G, et al. DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients. Eur J Hum Genet 2020 ; 28 : 64–75. [CrossRef] [PubMed] [Google Scholar]
- Bardin E, Pranke I, Hinzpeter A, Sermet-Gaudelus I. Traitements de la mucoviscidose : révolution clinique et nouveaux défis. Med Sci (Paris) 2024 ; 40 : 258–67. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Robinson KS, Toh GA, Firdaus MJ, et al. Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosis. J Exp Med 2023 ; 220 : e20230105. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.